Godrej Agorvet, in FY25, witnessed less than stellar volume/revenue growth across segments, bogged down by a weak demand environment and tepid volumes for dairy/animal feed/vegetable oil segments. (Source: Company Website)
Godrej Agrovet had seen its earnings trajectory over FY20–24 slow down to 3.4% (EPS CAGR) vs. a robust 11.7% over FY14–19 amid Covid-19, volatile rainfall patterns and the larger base (due to Astec acquisition in 2015) driving slower growth. FY25 has seen a welcome return to growth, with a 16% YoY jump in Ebitda and a 19% jump in net earnings, driven by a sharp improvement in realisations/margins and marginal improvements in revenues...